Show/hide main menu

Dr Michael Antoniou

Recent Publications

Recent Publications

Myers JP, Antoniou MN, Blumberg B, Carroll L, Colborn T, Everett LG, Hansen M, Landrigan PJ, Lanphear BP, Mesnage R, Vandenberg LN, Vom Saal FS, Welshons WV, Benbrook CM. (2016) Concerns over use of glyphosate-based herbicides and risks associated with exposures: a consensus statement. Environ Health., 15: 19.

Christodoulou I, Patsali P, Stephanou C, Antoniou M, Kleanthous M, Lederer CW. (2016) Measurement of lentiviral vector titre and copy number by cross-species duplex quantitative PCR. Gene Ther. 23: 113-118.

Mesnage R, Arno M, Costanzo M, Malatesta M, Séralini GE and Antoniou MN. (2015) Transcriptome profile analysis reflects rat liver and kidney damage following chronic ultra-low dose Roundup exposure.  Environ Health. 14: 70.

Saunders F, Sweeney B, Antoniou MN, Stephens P and Cain K. (2015) Chromatin Function Modifying Elements in an Industrial Antibody Production Platform - Comparison of UCOE, MAR, STAR and cHS4 Elements. PLoS ONE, 10(4): e0120096. 

Shields AM, Klavinskis LS, Antoniou M, Wooley PH, Collins HL, Panayi GS, Thompson SJ and Corrigall VM. (2014) Systemic gene transfer of binding immunoglobulin protein (BiP) prevents disease progression in murine collagen-induced arthritis. Clin Exp Immunol. 179: 210-219.

Dighe N, Khoury M, Mattar C, Chong M, Choolani M, Chen J, Antoniou MN and Chan JK (2014) Long-Term Reproducible Expression in Human Fetal Liver Hematopoietic Stem Cells with a UCOE-Based Lentiviral Vector. PLoS ONE, 9(8):e104805. doi: 10.1371/journal.pone.0104805.

Jonuschies J, Antoniou M, Waddington S, Boldrin L, Muntoni F, Thrasher A and Morgan J. (2014) The human desmin promoter drives robust gene expression for skeletal muscle stem cell-mediated gene therapy. Curr Gene Ther. 14: 276-288.

So MY, Tian Z, Phoon YS, Sha S, Antoniou MN, Zhang JW, Wu RS, Tan-Un KC (2014) Gene Expression Profile and Toxic Effects in Human Bronchial Epithelial Cells Exposed to Zearalenone. PLoS ONE 9(5):e96404.

Träger U, Andre R, Lahiri N, Magnusson-Lind A, Weiss A, Grueninger S, McKinnon C, Sirinathsinghji E, Kahlon S, Pfister EL, Moser R, Hummerich H, Antoniou M, Bates GP, Luthi-Carter R, Lowdell MW, Björkqvist M, Ostroff GR, Aronin N, Tabrizi SJ. (2014) HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation. Brain, 137: 819-833.

Sitemap Site help Terms and conditions Privacy policy Accessibility Modern slavery statement Contact us

© 2017 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454